TP53 and diabetes mellitus: For example, pharmacological inhibition or genetic deletion of p53 in human cardiac microvascular ECs promoted in vitro angiogenesis, whilst mice with EC-specific deletion of p53 showed enhanced vessel formation following both hindlimb ischaemia and induction of experimental diabetes [71, 75].